Bruker Corporation
BRKRP
Get informed when a big investor buys or sells
+ FollowMarket Cap$63.19B
Close$
$8.99
97.8% downside
Current Fair Value
97.8% downsideOvervalued by 97.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $63.19 Billion |
|---|---|
| Enterprise Value | $65.37 Billion |
| Dividend Yield | $15.63 (0.34%) |
| Earnings per Share | $-0.15 |
| Beta | 1.39 |
| Outstanding Shares | 152,200,000 |
Return
| Return on Equity | -2.97% |
|---|---|
| Return on Assets | -1.18% |
| Return on Invested Capital | 0.51% |
Valuation & Multiples
| P/E Ratio | -84.18 |
|---|---|
| PEG | 10.73 |
| Price to Sales | 18.87 |
| Price to Book Ratio | 27.68 |
| Enterprise Value to Revenue | 18.68 |
| Enterprise Value to EBIT | 2668.12 |
| Enterprise Value to Net Income | -919 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.98 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$0.38
Average shareholder expectationRevenue Estimate
$853.57 M
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$0.42
Average shareholder expectationRevenue Estimate
$865.19 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Bruker Corp
6,000 employees
CEO: Frank Laukien Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable...